L-Glutamic acid, L-α-aspartyl-L-leucyl-L-α-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolylglycyl-L-arginyl-L-phenylalanyl-L-α-aspartyl-L-arginyl-L-arginyl-L-valyl-O-phosphono-L-seryl-L-valyl-L-alanyl-L-alanyl-
L-Glutamic acid, L-α-aspartyl-L-leucyl-L-α-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolylglycyl-L-arginyl-L-phenylalanyl-L-α-aspartyl-L-arginyl-L-arginyl-L-valyl-O-phosphono-L-seryl-L-valyl-L-alanyl-L-alanyl- Basic information
- Product Name:
- L-Glutamic acid, L-α-aspartyl-L-leucyl-L-α-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolylglycyl-L-arginyl-L-phenylalanyl-L-α-aspartyl-L-arginyl-L-arginyl-L-valyl-O-phosphono-L-seryl-L-valyl-L-alanyl-L-alanyl-
- Synonyms:
-
- L-Glutamic acid, L-α-aspartyl-L-leucyl-L-α-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolylglycyl-L-arginyl-L-phenylalanyl-L-α-aspartyl-L-arginyl-L-arginyl-L-valyl-O-phosphono-L-seryl-L-valyl-L-alanyl-L-alanyl-
- CAS:
- 103659-06-9
- MF:
- C92H151N28O32P
- MW:
- 2192.33
- Mol File:
- 103659-06-9.mol
More
Less
L-Glutamic acid, L-α-aspartyl-L-leucyl-L-α-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolylglycyl-L-arginyl-L-phenylalanyl-L-α-aspartyl-L-arginyl-L-arginyl-L-valyl-O-phosphono-L-seryl-L-valyl-L-alanyl-L-alanyl- Chemical Properties
- Density
- 1.52±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)
- Sequence
- Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-{pSer}-Val-Ala-Ala-Glu
More
Less
L-Glutamic acid, L-α-aspartyl-L-leucyl-L-α-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolylglycyl-L-arginyl-L-phenylalanyl-L-α-aspartyl-L-arginyl-L-arginyl-L-valyl-O-phosphono-L-seryl-L-valyl-L-alanyl-L-alanyl- Usage And Synthesis
Uses
PKA Regulatory Subunit II Substrate (RII phosphopeptide) is a tool peptide derived from the regulatory subunit Type II (RII) of cyclic AMP-dependent protein kinase (PKA). PKA Regulatory Subunit II Substrate is commonly used to mimic the phosphorylation of protein kinases and as a specific substrate for protein phosphatases to assess the activities of these enzymes[1].
References
[1] Wang Lu, et al. "A novel peptide exerts potent immunosuppression by blocking the two-site interaction of NFAT with calcineurin." Journal of Biological Chemistry 295.9 (2020): 2760-2770. DOI:10.1074/jbc.RA119.010254
L-Glutamic acid, L-α-aspartyl-L-leucyl-L-α-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolylglycyl-L-arginyl-L-phenylalanyl-L-α-aspartyl-L-arginyl-L-arginyl-L-valyl-O-phosphono-L-seryl-L-valyl-L-alanyl-L-alanyl-Supplier
Nanjing Typeptide Biotechnology Co.,Ltd.
- Tel
- 19941518170
- sales@typeptide.com
Fuan Bio
- Tel
- 18178976185
- 3855357086@qq.com
More
Less
L-Glutamic acid, L-α-aspartyl-L-leucyl-L-α-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolylglycyl-L-arginyl-L-phenylalanyl-L-α-aspartyl-L-arginyl-L-arginyl-L-valyl-O-phosphono-L-seryl-L-valyl-L-alanyl-L-alanyl-(103659-06-9)Related Product Information
- KRL74
- Salivaricin B
- L-Lysine, glycyl-L-lysyl-L-cysteinyl-L-seryl-L-threonyl-L-arginylglycyl-L-arginyl-L-lysyl-L-cysteinyl-L-cysteinyl-L-arginyl-L-arginyl-L-lysyl-
- Lucicebtide
- KSL 128114
- NOTA-P2-RM26
- Myelopeptide 4
- PDpep1.3
- Ac-D-W-F-K-A-F-Y-D-K-V-A-E-K-F-K-E-A-F-NH2
- L-PYROGLUTAMYL-L-ARGINYL-L-THREONYL-L-LYSYL-L-ARGININE 4-METHYLCOUMARYL-7-AMIDE